The Rebecca L. Cooper Medical Research Foundation is a registered and self-funded charity which has as its object, the advancing, promoting and encouraging of medical research in Australia.


Professor Andrew Lawrence
Behavioural Neuroscience Division, Flory Neuroscience Institutes at Melbourne Brain Centre, University of Melbourne
“Identifying genes implicated in addiction.”

Dr Laura Gray
School of Medicine, Deakin University
“Oxidative stress in mood disorders.”

Associate Professor Andreas Hofmann
Structural Chemistry Program, Eskitis Institute for Cell & Molecular Therapies, Griffith University
“Molecular probing and structure-based drug design of protein targets in infection and neurological diseases.”

Professor Ian Everall
Melbourne Brain Centre, Department of Psychiatry
“Investigation of the expression and function of selenium binding protein-1 (SELENBP1) in schizophrenia.”

Professor Glenda Halliday
Neuroscience Australia
“Brain and DNA donation for aging and neurodegeneration research.”

Dr Emily Mathey
Neuroinflammation Laboratory, Brain and Mind Research Institute (BMRI), Central Clinical School, University of Sydney
“Novel auto-antibodies to nervous system antigens in paralyzing disorders.”

Dr Michael Weible
The Eskitis Institute for cell and molecular therapies, National centre for adult stem cell research, Griffith University
“Zeiss PALM Laser microdissection stage incubation for Live-Cell investigations into human neuroepithelial stem cell calcium physiology.”

Associate Professor Chris Williams
The Bionics Institute
“Electrode development for Deep Brain Stimulation research.”

Mr David Ziegler
Children’s Cancer Institute
“Developing Novel therapeutic treatments for childhood brain cancers.”

Dr Randal Moldrich
“Centre for Advanced Imaging The University of Queensland
The role of epigenetics in epilepsy.”

Dr Louise Cole
Bosch Institute advanced microscopy facility
“Upgrade of the palm duoflex combi laser microdissection and optical tweezers system to a high resolution and improved live-cell imaging platform using an Apotome.2 slider and associated software.”

Dr Valery Combes
Vascular Immunology Unit, Department of pathology, Sydney Medical School, The University of Sydney
“In vivo characterisation and role of microparticles during neuroinfection.”

Dr Marcel Batten
Immunology Department, The Garvan Institute of Medical Research
“Understanding the function of novel genes associated with development of Multiple Sclerosis.”

Dr Graeme Polglase
The Ritchie Centre, Monash Institute of Medical Research, Monash University
“Protecting the brain from external factors at preterm birth.”

Dr Michael Lovelace
Discipline of Anatomy and Histology, Bosch Institute, The University of Sydney
“An Investigation of purinergic nucleotides in directing the differentiation of human neural precursor cell populations: application to cell therapy for Parkinson’s disease.”

Stanley Stylli
Department of Neurosurgery, The Royal Melbourne Hospital
“Treatment of brain tumors utilising the ‘nanosponge delivery system’ (NDS).”

Professor Cheryl Jones
The University of Sydney, The Children’s Hospital at Westmead Clinical School
“What is the profile and burden of cerebral palsy (CP) due to congenital cytomegalovirus (CMV) infection in Australia – population based molecular testing for CMV on stored newborn screening cards from children on Australian National CP register.”


Associate Professor Susan McLennan
University of Sydney, Discipline of Medicine
“The Study of diabetes and its complications.”

Professor Greg Barritt
Medical Biochemistry, School of Medicine, Faculty of Health Sciences, Flinders University
“Mechanism of impaired signaling in the liver in insulin resistance.”

Dr Maria Craig
School of Women’s and Children’s Health, University of New South Wales, Institute of Endocrinology and Diabetes, Children’s Hospital at Westmead, and Virology Research
Laboratory, Prince of Wales Hospital, Randwick
“Assessing human enteroviruses as a cause of type 1 diabetes mellitus – virulence determinants and β-cell tropism.”

Associate Professor Alicia Jenkins
The University of Melbourne, Department of Medicine, St Vincent’s Hospital
“Retinal vascular health in diabetes as a measure of systemic blood vessel health, Advanced Glycation End Product burden, and diabetes complication risk.”

Professor Michael Horowitz
University of Adelaide, Discipline of Medicine, Royal Adelaide Hospital
“Measurement of blood glucose in patients with diabetes and critical illness induced hyperglycaemia.”

Professor David James
Diabetes and Obesity Research Program, The Garvan Institute of Medical Research
“A proteomics and systems biology approach to investigate insulin signaling and type 2 diabetes.”

Dr Ann Simpson
School of Medical & Molecular Biosciences, University of Technology, Sydney
“Low temperature storage facility for production of insulin-secreting liver cells.”


Dr Chuck Bailey
Gene & Stem Cell Therapy Program, Centenary Institute
“Determining the genetics of response to treatment in Chronic Myeloid Leukaemia (CML).”

Dr Ruth MacKinnon
Victorian Cancer Cytogenetics Service (VCCS), St Vincent’s Hospital (Melbourne) Ltd
“Using multicoloured chromosomes as a tool to help understand chromosome mis-division.”

Dr Kelly Rogers
Centre for Dynamic Imaging, Walter & Eliza Hall Institute of Medical Research
“High performance LEDs for live-cell imaging.”

Associate Professor Kathryn North
The Institute of Neuroscience and Muscle Research (INMR), The Children’s Hospital at Westmead
“Improving the genetic diagnosis of neuromuscular diseases.”

Dr Viive Howell
Cancer NSW Institute Research Fellow, Functional Genomics Laboratory, Kolling Institute of Medical Research, Royal North Shore Hospital
“Scanning for mutations in cancer susceptibility genes.”


Dr Anne Poljak
Bioanalytical Mass Spectrometry Facility, University of New South Wales
“Protein profiling of plasma in normal aging and early dementia.”

Professor Derek Hart
Dendritic Cell Biology and Therapeutics Laboratory, ANZAC Research Institute, Concord Hospital
“RNA loading of tumour associated antigens and the activation of blood dendritic cells for
prostate cancer immunotherapy.”

Associate Professor Hala Zreiqat
Biomaterials and Tissue Engineering Research Unit, School of Aerospace, Mechanical and Mechatronic Engineering, University of Sydney
“A basis for building bone: Novel biomaterials for new bone growth.”


Professor Anthony Weiss
Molecular Bioscience, The University of Sydney
“Novel treatment of damaged airway.”

Dr Alexander Larcombe
Division of Clinical Sciences, Telethon Institute for Child Health Research
“Rhinovirus impairs physiological and immunological lung development and causes exacerbation of alle
rgic airways disease.”

Dr Daniel Chambers
Department of Thoracic Medicine, The Prince Charles Hospital
“The Human Lung Microbiome Project.”

Dr Gabrielle Belz
Division of molecular immunology, Walter and Eliza Hall Institute of Medical Research
“Cellular and transcriptional mechanisms regulating immune responses in the lung microenvironment.”

Professor Warwick Britton
Myobacterial Research Program, Centenary Institute of Cancer Medicine and Cell Biology
“Function and diagnostic potential of Microparticles induced by Mycobacterium tuberculosis infection in the lung.”


Professor Ian Wicks
Inflammation division, Walter & Eliza Hall Institute of Medical Research
“Applying serum proteomics to the study of rheumatoid arthritis.”

Dr Thomas Gethin
University of Queensland Diamantina Institute, Princess Alexandra Hospital
“Assessment of novel treatments in ankylosing spondylitis.”

Professor John Hamilton
Department of Medicine, Royal Melbourne Hospital
“Graniocyte macrophage colony-stimulating factor (GM-CSF) ‘gene signature’ in patients with
rheumatoid arthritis (RA).”


Dr Jelena Kezic
Department of Anatomy and Developmental Biology (School of Biomedical Sciences), Monash
“The role of retinal microglia in a mouse model of spontaneous early onset of hyperglycaemia.”

Professor Tailoi Chan-Ling
Retinal and developmental neurobiology laboratory, Bosch Institute, Discipline of Anatomy and Histology, Sydney Medical School, The University of Sydney
“Development and ageing of the human choroidal vasculature: Role of stem cells,
lymphangiogenesis and novel pro- and anti-angiogenic growth factors as targets in treating Wet Age Related Macular Degeneration (MD).”

Professor Minas Coroneo
Department of Ophthalmology, The Prince of Wales Hospital, Randwick. Also under the
supervision of UNSW
“Novel techniques for the creation of conjunctival grafts.”